CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
Maurizio Cianfriglia, Valentina Fiori, Sabrina Dominici, Silvia Zamboni, Michela Flego, Maria Luisa Dupuis, Alessandro Ascione, Mara Gellini, Alessandra Mallano and Mauro Magnani
The Open Pharmacology Journal, 2012; 6: 1.
Electronic Publication Date: November 23, 2012Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data
H. Douna, B.M. Bavelaar, H. Pellikaan, B. Olivier and T. Pieters
The Open Pharmacology Journal, 2012; 6: 12.
Electronic Publication Date: May 9, 2012Functional Role of Glycosylation in a Human IgG4 Antibody Assessed by Surface Plasmon Resonance Technology
Rosie B. Wong, Ming Zeng, An-Horng Lee, T. Shantha Raju and Kuang-Chuan Cheng
The Open Pharmacology Journal, 2012; 6: 27.
Electronic Publication Date: May 9, 2012Intelligent Systems and the Systematization of Pharmacological Knowledge: Application of the In Vitro Retina Model
Vera Maura Fernandes de Lima, Jose Airamir Padilha de Castro and Wolfgang Hanke
The Open Pharmacology Journal, 2012; 6: 34.
Electronic Publication Date: May 9, 2012Primary Sclerosing Cholangitis - Current Issues in Clinical Practice
L. Corless and H. Tsai
The Open Pharmacology Journal, 2012; 6: 45.
Electronic Publication Date: October 9, 2012
